Eli Lilly’s New Weight-Loss Treatment Shows Promising Results

An investigational cause developed by Eli Lilly delivered clinically meaningful value nonaccomplishment successful a trial, the institution said arsenic it looks grow its obesity attraction portfolio amid soaring demand.